02/28/2026
Chronic migraine is a complex neurological condition that can significantly impact work, relationships, and overall quality of life. Research also shows that many patients face barriers to diagnosis and treatment depending on their background or access to care.
A study called the COMPEL trial recently explored an important question: Do preventive migraine treatments work similarly for people from different racial and ethnic groups?
Our Medical Director, Dr. Deena Kuruvilla, served as a study author in the post-hoc analysis of this phase-4 COMPEL trial and was recently interviewed by NeurologyLive® to discuss the findings.
Today we will discuss what the findings mean for patients.
Check out the full blog post at the link in our bio!